Conferences

September 2026: BPI Boston 2026

Written by KBI Biopharma | Aug 26, 2026, 3:40:37 PM

Join KBI Biopharma at BioProcess International (BPI) Boston 2026

When: September 22-25, 2026

Where: Boston, Massachusetts

Join KBI Biopharma at BioProcess International (BPI) East 2026 to discover how our integrated development and manufacturing expertise helps advance biologics from early development through commercial production. From cell line and process development to analytical services and cGMP manufacturing, KBI combines scientific expertise with scalable solutions to help reduce risk, accelerate timelines, and prepare your program for what’s next.

Schedule a meeting >>

Meet with the KBI Biopharma Team:

Why Stop by the KBI Booth?


Integrated Solutions: From cell line development and analytical services to process development and cGMP manufacturing, KBI provides integrated solutions that help reduce risk and streamline the path from early development through commercial production. One partner. Integrated expertise.

Scientific Excellence: Explore advanced cell line, analytical, formulation, and process development capabilities designed to improve process understanding, optimize performance, and build confidence as your biologic advances.

Scalable Manufacturing: Discover KBI’s mammalian and microbial manufacturing capabilities and how the right development and manufacturing strategy can help minimize technology transfer risk, improve scale-up confidence, and prepare for commercial supply.

Expert Consultation: Meet with KBI’s scientists and development experts to discuss your molecule, address technical challenges, and identify practical strategies for reaching your next development milestone.

 

Hear from KBI Experts at BPI Boston


Beyond the booth, connect with KBI scientists and leaders throughout the conference as they share insights on next-generation cell line development, viral clearance, analytical development, and accelerating innovation.

Featured Presentation: Sigma Mostafa presents "Evolving Cell Line Development for Next-Generation Biotherapeutics", exploring strategies to meet the evolving needs of increasingly complex molecules.

BIG Executive Summit: Leslie Wolfe will co-facilitate a roundtable bringing together industry leaders to explore how biopharma can accelerate innovation and shorten the path from breakthrough ideas to commercial impact.

Poster Presentations: Explore new research from Leslie Wolfe on dual virus spiking for more efficient viral clearance evaluation, Myriam Adam on ClearCHO™ and addressing CHO-inherent RVLP challenges at the source, and Derek Ryan on platform solutions for accelerating biologics development.

 Stop by KBI booth #505 to meet our experts, explore the latest science, and discuss your program, or book a one-on-one meeting with our team

 

About KBI Biopharma: 

KBI Biopharma is a leading global contract development and manufacturing organization (CDMO) providing fully integrated, accelerated drug development and biologics manufacturing services and expertise to life science companies. With each of our 1400+ client partners, we work closely to personalize and accelerate drug development programs. Built upon a foundation of world-class analytics capabilities and extensive scientific and technical expertise, we deliver robust process development and clinical and commercial cGMP manufacturing services for mammalian and microbial programs. Recognized for quality manufacturing, we help clients advance drug candidates into the clinic and beyond. 

Learn more about KBI Biopharma >>

 

About the Event: 

The BioProcess International (BPI) East Conference brings together more than 3,200 scientists, engineers, and bioprocessing professionals to explore the latest advances across biologics development and manufacturing. As a premier forum for the biomanufacturing industry, BPI East covers the full bioprocessing lifecycle, from early innovation and process development through scale-up and manufacturing, connecting industry leaders with the technologies and strategies shaping the future of biologics.